» Articles » PMID: 39275854

Efficacy and Safety of Flow Diverters in Retreatment of Recurrent Intracranial Aneurysms-A Systematic Review and Meta-analysis

Overview
Publisher Sage Publications
Specialty Neurology
Date 2024 Sep 14
PMID 39275854
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Treatment of recurrent intracranial aneurysms after their initial therapy has been a significant challenge in the field of neurointervention. Recently flow diverters stents are widely used for treating intracranial aneurysms. In this systematic review and meta-analysis, we assessed the safety and efficacy of flow diverter in treating recurrent or recanalized intracranial aneurysms.

Methods: This meta-analysis is reported following the PRISMA 2020 guidelines. We conducted a systematic review of literature in the PubMed, Embase, Web of Sciences, and Scopus databases. Pooled prevalence and the corresponding 95% are calculated from extracted data using a random-effect model.

Results: The systematic literature search included 21 studies involving 411 patients, with 135 (32.8%) being male and 276 (67.2%) being females with a total number of 447 aneurysms. The overall rate of adequate occlusion was 90.67% (95% CI: 84.23%-94.65%), and the rates were comparable between the surgery (93.48%), coiling (91.78%), and stenting (85.77%) groups. The overall pooled rate of complete occlusion was 81.80 (95% CI: 71.14%-89.13%). On doing a subgroup analysis, the complete occlusion rates were 89.68%, 84.39%, and 73.47% for the surgery, coiling, and stenting groups, respectively. The overall mortality rate and achieving modified Rankin scale score of 0-2 was 1.28% (95% CI: 0.45%-3.64%) and (95% CI: 89.92%-97.84%), respectively. No significant heterogeneity is noted in the included studies.

Conclusion: Flow diverter stents are an effective and safe method for retreating recurrent or residual intracranial aneurysms with a high rate of complete and adequate occlusion. The rate of mortality, intracerebral hemorrhage, and overall and procedural complications following using flow diverters for intracranial aneurysms is low.

References
1.
Daou B, Starke R, Chalouhi N, Tjoumakaris S, Hasan D, Khoury J . Pipeline Embolization Device in the Treatment of Recurrent Previously Stented Cerebral Aneurysms. AJNR Am J Neuroradiol. 2015; 37(5):849-55. PMC: 7960319. DOI: 10.3174/ajnr.A4613. View

2.
Akgul E, Onan H, Islek I, Tonge M, Durmus Y, Barburoglu M . Flow diverter stents in the treatment of recanalized intracranial aneurysms. Interv Neuroradiol. 2021; 27(4):481-489. PMC: 8580529. DOI: 10.1177/1591019921990507. View

3.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

4.
Duval S, Tweedie R . Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56(2):455-63. DOI: 10.1111/j.0006-341x.2000.00455.x. View

5.
Heiferman D, Billingsley J, Kasliwal M, Johnson A, Keigher K, Frudit M . Use of flow-diverting stents as salvage treatment following failed stent-assisted embolization of intracranial aneurysms. J Neurointerv Surg. 2015; 8(7):692-5. DOI: 10.1136/neurintsurg-2015-011672. View